Suppr超能文献

高氟化寡核苷酸两亲物的自组装及生物学性质

Self-Assembly and Biological Properties of Highly Fluorinated Oligonucleotide Amphiphiles.

作者信息

Laurent Quentin, Bona Beatrice L, Asohan Jathavan, Rosati Marta, Faiad Sinan, Bombelli Francesca Baldelli, Metrangolo Pierangelo, Sleiman Hanadi F

机构信息

Department of Chemistry, McGill University, 801 Sherbrooke St. W, QC-H3A 0B8, Montreal, Canada.

SupraBioNano Lab, Department of Chemistry, Materials, and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Luigi Mancinelli 7, MI-20131, Milano, Italy.

出版信息

Angew Chem Int Ed Engl. 2025 Feb 10;64(7):e202419996. doi: 10.1002/anie.202419996. Epub 2024 Dec 17.

Abstract

Nucleic acids, used as therapeutics to silence disease-related genes, offer significant advantages over small molecule drugs: they provide high specificity, the ability to target "undruggable" molecules, and adaptability to a wide range of disease phenotypes. However, their instability in biological media, as well their rapid clearance from the organism limit their applicability, necessitating the use of nanocarriers to overcome these challenges. Among these strategies, spherical nucleic acids (SNA)-composed of a densely packed corona of oligonucleotides around a nanoparticle-have emerged as a powerful tool, in particular when self-assembled from DNA amphiphiles. This non-covalent strategy however has caveats, especially when it comes to stability in complex biological media, where these SNAs disassemble in contact to serum proteins. Here, we developed highly fluorinated DNA amphiphiles that readily self-assemble into SNAs and have tunable stability profiles in biological media. They are made of branched fluorinated moieties with potentially improved biodegradability as compared to their linear counterparts. Depending on the number of fluorophilic interactions, the self-assembled SNAs can have excellent serum stabilities-up to days-and readily deliver nucleic acid therapeutics for gene silencing applications. These systems show great potential as promising candidates for nucleic acid-based therapies.

摘要

核酸作为一种用于沉默疾病相关基因的治疗手段,与小分子药物相比具有显著优势:它们具有高度特异性,能够靶向“不可成药”分子,并且能适应多种疾病表型。然而,它们在生物介质中的不稳定性以及从生物体中的快速清除限制了其应用,因此需要使用纳米载体来克服这些挑战。在这些策略中,球形核酸(SNA)——由围绕纳米颗粒的紧密堆积的寡核苷酸冠层组成——已成为一种强大的工具,特别是当由DNA两亲分子自组装而成时。然而,这种非共价策略存在一些问题,尤其是在复杂生物介质中的稳定性方面,在这种介质中,这些SNA与血清蛋白接触时会解体。在这里,我们开发了高度氟化的DNA两亲分子,它们很容易自组装成SNA,并且在生物介质中具有可调节的稳定性。它们由支链氟化部分组成,与线性对应物相比,其生物降解性可能有所提高。根据亲氟相互作用的数量,自组装的SNA可以具有出色的血清稳定性——长达数天——并且能够轻松递送用于基因沉默应用的核酸治疗剂。这些系统作为基于核酸的治疗方法的有前途的候选者显示出巨大的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验